DOTAGA-Trastuzumab. A New Antibody Conjugate Targeting HER2/<i>Neu</i> Antigen for Diagnostic Purposes
2012 · Bioconjugate Chemistry · 41 citations
https://doi.org/10.1021/bc200680x
J
Jean‐Marc Vrigneaud
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
955
Citations
18
h-index
26
i10-index
Jean‐Marc Vrigneaud is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: Medical Imaging Techniques and Applications & Radiomics and Machine Learning in Medical Imaging & Radiopharmaceutical Chemistry and Applications. The author has an h-index of 18, co-authored 73 publications.
ORCID: 0000-0002-3441-7520Papers by this author
worksHealth-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial)
2021 · European Journal of Cancer · 18 citations
https://doi.org/10.1016/j.ejca.2021.05.032
Navigating the nuances: comparative analysis and hyperparameter optimisation of neural architectures on contrast-enhanced MRI for liver and liver tumour segmentation
2024 · Scientific Reports · 11 citations
https://doi.org/10.1038/s41598-024-53528-9
[123I]MIBG is a better early marker of anthracycline cardiotoxicity than [18F]FDG: a preclinical SPECT/CT and simultaneous PET/MR study
2021 · EJNMMI Research · 9 citations
https://doi.org/10.1186/s13550-021-00835-1
Multi-modal image fusion for small animal studies in in-line PET /3T MRI
2015 · HAL (Le Centre pour la Communication Scientifique Directe) · 1 citations
Implementation of routine sequential PET/MR of the rat heart in an in-line preclinical scanner
2016 · HAL (Le Centre pour la Communication Scientifique Directe) · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat